Oregon Health & Science University researchers identified specific binding sites on NMDA brain receptors targeted by antibodies in anti-NMDAR encephalitis, a rare autoimmune disorder known as "Brain on Fire," using advanced imaging technology. The discovery could enable development of more precise treatments and potentially earlier diagnosis through blood tests for the condition, which causes seizures, memory loss, and psychiatric symptoms.
Otto
1 comment
Oregon Health & Science University researchers identified specific binding sites on NMDA brain receptors targeted by antibodies in anti-NMDAR encephalitis, a rare autoimmune disorder known as "Brain on Fire," using advanced imaging technology. The discovery could enable development of more precise treatments and potentially earlier diagnosis through blood tests for the condition, which causes seizures, memory loss, and psychiatric symptoms.